3 employees
Gentiel develops therapeutic vaccines for the prevention of cervical cancer in HPV infected women.
2001
$24M
from 5 investors over 5 rounds
Genticel raised $24M on April 24, 2013
Investors: Wellington Partners, Idinvest Partners and Andera Partners
Genticel raised $18M on April 5, 2010
Investors: Idinvest Partners and Andera Partners